H Kurita, N Uzawa, H Nakayama, T Abe, S Ibaraki, Y Ohyama, K Uchida, H Sato, S Miyabe, T Abé, N Kakimoto, A Kaida, T Sugiura, M Kioi, A Danjo, N Kitamura, O Hasegawa, T Tanaka, N Ueda, T Hasegawa, S Asoda, H Katsuta, S Yanamoto, S Yamada, D Takeda, T Suzuki, Y Ohta, T Kirita
{"title":"Japanese clinical practice guidelines for oral cancer, 2023.","authors":"H Kurita, N Uzawa, H Nakayama, T Abe, S Ibaraki, Y Ohyama, K Uchida, H Sato, S Miyabe, T Abé, N Kakimoto, A Kaida, T Sugiura, M Kioi, A Danjo, N Kitamura, O Hasegawa, T Tanaka, N Ueda, T Hasegawa, S Asoda, H Katsuta, S Yanamoto, S Yamada, D Takeda, T Suzuki, Y Ohta, T Kirita","doi":"10.1016/j.ijom.2024.11.012","DOIUrl":null,"url":null,"abstract":"<p><p>The Japanese Society of Oral Oncology and Japanese Society of Oral and Maxillofacial Surgeons have jointly developed clinical practice guidelines for oral cancer (oral squamous cell carcinoma) to improve and standardize the quality of oral cancer treatment in Japan. The first, second, and third editions were published in 2009, 2013, and 2019, respectively, and the 2023 edition was recently developed. In the development of the 2023 edition, 60 clinical questions (CQs) were listed. Systematic reviews following the GRADE approach were performed for 11 of these CQs. This article outlines the 2023 edition and describes the most relevant guidelines and CQs for the diagnosis, treatment, follow-up, and supportive care of oral cancer patients in Japan.</p>","PeriodicalId":94053,"journal":{"name":"International journal of oral and maxillofacial surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of oral and maxillofacial surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ijom.2024.11.012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The Japanese Society of Oral Oncology and Japanese Society of Oral and Maxillofacial Surgeons have jointly developed clinical practice guidelines for oral cancer (oral squamous cell carcinoma) to improve and standardize the quality of oral cancer treatment in Japan. The first, second, and third editions were published in 2009, 2013, and 2019, respectively, and the 2023 edition was recently developed. In the development of the 2023 edition, 60 clinical questions (CQs) were listed. Systematic reviews following the GRADE approach were performed for 11 of these CQs. This article outlines the 2023 edition and describes the most relevant guidelines and CQs for the diagnosis, treatment, follow-up, and supportive care of oral cancer patients in Japan.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
